To start this year's Myeloma Action Month, the IMF hosted a Facebook Live session at their headquarters in Los Angeles, USA to discuss the early findings from the ground-breaking study, iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma).

Launched in November 2016, the iStopMM project is the largest ever Myeloma project which involves screening for monoclonal gammopathy of undetermined significance (MGUS) in all of the Icelandic population over 40 years of age.

In this Facebook Live session, Dr Brian Durie (IMF Chairman), Dr Sigurdur Kristinsson (University of Iceland) and Dr Ste Harding (R&D Director at The Binding Site) talked about what the iStopMM project is and the results they have found so far. They also answered questions from viewers throughout.

The iStopMM project team invited over 148,000 people in Iceland to take part in this study via social media platforms such as Facebook, and gained the consent of 80,770 Icelanders (55% target population) to take part in this study. Working alongside The Binding Site, 32,000 – 35,000 samples have already been screened at the Birmingham Headquarters. Due to the screening process, 1,200 – 1,500 new cases have been detected which aligns with the iStopMM concept of early detection and treatment.

To find out more about the iStopMM project, you can view the video here